Sign in to view content

End-of-Study Retinal Fluid and Vision Outcomes in the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab in Patients With nAMD

Aleksandra V. Rachitskaya, MD, FASRS

Video
Published 2022

Related

Impact and Outcomes of Anti-VEGF Prior Authorization Requests: Insights From a Large Database Analysis
Saira Khanna, MD
Annual Meeting Talks
2023
Imaging Signatures and Cytokine Expression in Diabetic Macular Edema From the IMAGINE Study: Biomarker Exploration for Precision Medicine
Sruthi Arepalli, MD
On Demand Cases, Courses, and Papers
2020
Ranibizumab for Radiation Retinopathy (RRR) A Prospective, Multicenter Trial of Monthly Versus PRN Dosing for Radiation Retinopathy-Related Macular Edema
Rajiv Anand, MD, FRCS, FASRS
Annual Meeting Talks
2018

Category: AMD-Neovascular

See more